Page last updated: 2024-08-23

enterobactin and Dysentery, Bacillary

enterobactin has been researched along with Dysentery, Bacillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allavena, P; Béchet, S; Beveridge, N; Cosgrove, CA; Dupont, F; Fontaine-Thompson, A; Frazer, S; Giemza, R; Griffin, GE; Johnson, J; Jolly, N; Lewis, DJ; Liddy, H; Mantovani, A; Ndiaye, A; Sadorge, C; Sansonetti, PJ	1

Trials

1 trial(s) available for enterobactin and Dysentery, Bacillary

Article	Year
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers. Vaccine, 2008, Feb-13, Volume: 26, Issue:7 Topics: Administration, Oral; Adult; Antibodies, Bacterial; Bacterial Proteins; DNA-Binding Proteins; Dysentery, Bacillary; Enterobactin; Female; Gene Deletion; Humans; Male; Protein Subunits; Shiga Toxin; Shigella dysenteriae; Shigella Vaccines; Transcription Factors; Treatment Outcome; Vaccines, Attenuated	2008

Article

Year

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.

Vaccine, 2008, Feb-13, Volume: 26, Issue:7

Topics: Administration, Oral; Adult; Antibodies, Bacterial; Bacterial Proteins; DNA-Binding Proteins; Dysentery, Bacillary; Enterobactin; Female; Gene Deletion; Humans; Male; Protein Subunits; Shiga Toxin; Shigella dysenteriae; Shigella Vaccines; Transcription Factors; Treatment Outcome; Vaccines, Attenuated

2008